Reducing Time to Market for Pharma Companies with Rapid Payer Response
Subscribe on any major podcast player.
Typically, it takes several months for third-parties and consultants in the life sciences industry to get data back to pharmaceutical companies with payer research. Today's guest is Baiju Aurora, CEO of Market Access Transformation (MAT) is shrinking getting payer response research to a few days.
Baiju has led the MAT team for more than five years and their first product, Rapid Payer Response, provides pharmaceutical companies payer research in only a few days from their payer network.
Baiju’s career has spanned pricing, market access, health economics, and outcomes research for bio pharmaceutical, medical device, and diagnostics companies.
Key Takeaways:
- Embrace unexpected clients
- Industry trends in pharmaceutical, including consolidation, execution, and how faster market research can propel pharmaceutical companies forward
- Consider building a company with profitability first in mind rather than scale and growth
Show Notes:
Market Access Transformation (MAT) - Rapid Payer Response
The Physician Payments Sunshine Act
Food Safety Preventive Controls Alliance (FSPCA)
General Data Protection Regulation (GDPR)
European Pharmaceutical Market Research Association (EphMRA)
U.S. Food and Drug Administration (FDA)
